APA
NMTR

American Portfolios Advisors’s 9 Meters Biopharma NMTR Stock Holding History

American Portfolios Advisors’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-500
Closed -$8.15K – 3122
2020
Q3 		$8.15K Buy
+500
New +$6.06K ﹤0.01% 2071
2019
Q1 		– Sell
-2
Closed -$99 – 2663
2018
Q4 		$99 Buy
+2
New +$148 ﹤0.01% 2367

Other funds holding NMTR

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TLP
Tri Locum Partners New York $713M AUM 68.92% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return

American Portfolios Advisors's NMTR Position: Q4 2020 in Review

American Portfolios Advisors sold out of 9 Meters Biopharma (NMTR) in Q4 2020, closing a stake of 500 shares — an estimated $8.15K sold.

American Portfolios Advisors first reported a position in NMTR in Q4 2018 and held it in 2 quarters. The position peaked at $8.15K in Q3 2020. 57 funds tracked by Wall St. Rank hold NMTR as of Q4 2020.

  • American Portfolios Advisors reported no remaining 9 Meters Biopharma position as of Q4 2020 after selling out during the quarter.
  • American Portfolios Advisors sold 500 9 Meters Biopharma shares in Q4 2020, an estimated $8.15K.
  • American Portfolios Advisors first reported a position in 9 Meters Biopharma in Q4 2018 and held it in 2 quarters.
  • American Portfolios Advisors's 9 Meters Biopharma position peaked at $8.15K in Q3 2020.
  • 57 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q4 2020.

Based on American Portfolios Advisors's 13F filing for Q4 2020, filed 22 Mar 2023.